SurGenTec LLC

SurGenTec is a privately held medical device manufacturer specializing in minimally invasive orthopedic and neurosurgical spine solutions. The company develops and markets a comprehensive portfolio of bone graft delivery systems, synthetic biologics, sacroiliac joint fusion implants, and spine stabilization hardware. Core product lines include the GraftGun® precision delivery system, OsteoFlo® bone void fillers (HydroFiber, HydroPutty, NanoPutty), TILINK® SI joint and lateral fusion systems, ION-C™ cervical stabilization, ALARA® Access Needle, and Ossify® cortical fiber grafts. SurGenTec's devices feature advanced surface technologies and are FDA-cleared for use across cervical, thoracic, and lumbar spine applications, including trauma, tumor, osteomyelitis, and degenerative indications. The company serves both domestic and international surgical markets through direct sales and distributor partnerships.